Karen J. Ferrante
2014
In 2014, Karen J. Ferrante earned a total compensation of $1.6M as Chief Medical Officer at Tokai Pharmaceuticals.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $109,477 |
| Option Awards | $1,145,830 |
| Salary | $249,292 |
| Other | $65,494 |
| Total | $1,620,093 |
Ferrante received $1.1M in option awards, accounting for 71% of the total pay in 2014.
Ferrante also received $50K in bonus, $109.5K in non-equity incentive plan, $249.3K in salary and $65.5K in other compensation.
Rankings
In 2014, Karen J. Ferrante's compensation ranked 5,430th out of 13,032 executives tracked by ExecPay. In other words, Ferrante earned more than 58.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,430 out of 13,032 | 58th |
Division Manufacturing | 1,942 out of 4,965 | 61st |
Major group Chemicals And Allied Products | 656 out of 1,690 | 61st |
Industry group Drugs | 506 out of 1,369 | 63rd |
Industry Pharmaceutical Preparations | 396 out of 1,042 | 62nd |
Source: SEC filing on April 29, 2016.
Ferrante's colleagues
We found two more compensation records of executives who worked with Karen J. Ferrante at Tokai Pharmaceuticals in 2014.